As of 2024-12-14, the Fair Value of Sangamo Therapeutics Inc (SGMO) is -4.41 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.05 USD, the upside of Sangamo Therapeutics Inc is -315.00%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -95.20 | -121.00 | -178.30 | -192.30 | -257.83 | -168.93 |
| YoY growth | -39.39% | -27.10% | -47.36% | -7.85% | -34.08% | -31.15% |
| Market Cap (mil) | 427.73 |
| P/E | |
| Forward P/E |
| EPS | -0.88 |
| Avg earnings growth rate | -31.15% |
| TTM earnings | -183.93 |